Published in Transplantation on January 01, 1989
Liver transplantation (1). N Engl J Med (1989) 4.53
Infections in solid-organ transplant recipients. Clin Microbiol Rev (1997) 2.86
Transplantation in HIV+ patients. Transplantation (1990) 1.29
Outcome of orthotopic liver transplantation in patients with haemophilia. Gut (1998) 0.89
Combined use of an immunotoxin and cyclosporine to prevent both activated and quiescent peripheral blood T cells from producing type 1 human immunodeficiency virus. Proc Natl Acad Sci U S A (1993) 0.88
Role of liver transplantation in human immunodeficiency virus positive patients. World J Gastroenterol (2015) 0.85
Current status of renal transplantation. West J Med (1990) 0.81
HIV testing in patients with end stage renal disease. BMJ (1990) 0.80
Liver Transplantation in the World: Present Conditions of Liver Transplantation from Cadaver Donors in USA. Kusuri No Chishiki (1995) 0.75
Surgery in HIV-1 and HIV-2 antibody positive patients. J Natl Med Assoc (1990) 0.75
Isolation of lymphocytopathic retroviruses from San Francisco patients with AIDS. Science (1984) 15.82
Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Results from the Multicenter AIDS Cohort Study. Lancet (1987) 4.33
Treatment of infections in patients with the acquired immunodeficiency syndrome. Ann Intern Med (1985) 4.02
Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation (1983) 3.60
Three-year incidence of AIDS in five cohorts of HTLV-III-infected risk group members. Science (1986) 3.31
Fungal infections in liver transplant recipients. Transplantation (1985) 3.07
The incidence rate of acquired immunodeficiency syndrome in selected populations. JAMA (1985) 3.00
Kaposi's sarcoma in recipients of renal transplants. Am J Med (1979) 2.45
Primary human T-lymphotropic virus type III infection. Ann Intern Med (1985) 2.40
Epstein-Barr virus, immunodeficiency, and B cell lymphoproliferation. Transplantation (1985) 2.34
The epidemiology and prevention of the acquired immunodeficiency syndrome. Ann Intern Med (1985) 2.16
Liver transplantation in hemophilia A. Blood (1987) 1.98
Prevalence of HTLV-III antibody in American blood donors. N Engl J Med (1985) 1.88
Importance of western blot analysis in predicting infectivity of anti-HTLV-III/LAV positive blood. Lancet (1985) 1.70
Blood donor sera with false-positive Western blot reactions to human immunodeficiency virus. Lancet (1986) 1.53
A model-based approach for estimating the mean incubation period of transfusion-associated acquired immunodeficiency syndrome. Proc Natl Acad Sci U S A (1986) 1.49
The natural history of Kaposi's sarcoma in the acquired immunodeficiency syndrome. Ann Intern Med (1985) 1.46
Detection of early antibodies in human immunodeficiency virus infection by enzyme-linked immunosorbent assay, Western blot, and radioimmunoprecipitation. J Clin Microbiol (1987) 1.37
Pneumocystis carinii pneumonia in renal-transplant recipients treated with cyclosporine and steroids. J Infect Dis (1984) 1.29
Association of herpesvirus infections with T-lymphocyte-subset alterations, glomerulopathy, and opportunistic infections after renal transplantation. N Engl J Med (1983) 1.23
Detection of human immunodeficiency virus by reverse transcriptase assay, antigen capture assay, and radioimmunoassay. J Clin Microbiol (1987) 1.21
Treatment of serious cytomegalovirus infections with 9-(1,3-dihydroxy-2-propoxymethyl)guanine in patients with AIDS and other immunodeficiencies. Collaborative DHPG Treatment Study Group. N Engl J Med (1986) 1.14
Transmission of AIDS virus at renal transplantation. Lancet (1985) 1.08
HTLV-III infection in kidney transplant recipients. Lancet (1985) 1.03
Transfusion-acquired human immunodeficiency virus infection among immunocompromised persons. Ann Intern Med (1986) 0.97
Human immunodeficiency virus infection transmitted from an organ donor screened for HIV antibody--North Carolina. MMWR Morb Mortal Wkly Rep (1987) 0.84
Investigation of HTLV-3 serology in a renal transplant population. Transplantation (1987) 0.83
HTLV-III/LAV infection in kidney and liver transplantation. Transplant Proc (1987) 0.82
Transfusion-associated human T-lymphotropic virus type III/lymphadenopathy-associated virus infection from a seronegative donor--Colorado. MMWR Morb Mortal Wkly Rep (1986) 0.82
Transmission of human immunodeficiency virus by transplantation of a renal allograft, with development of the acquired immunodeficiency syndrome. Ann Intern Med (1987) 0.80
Severe immunosuppression in a renal transplant recipient with HTLV-III antibodies. Transplantation (1986) 0.80
Antibody against the human immunodeficiency virus in commercial intravenous gammaglobulin preparations. Ann Intern Med (1986) 0.78
Effect of herpesvirus infections on T-lymphocyte subpopulations and blastogenic responses in renal transplant recipients receiving cyclosporine. Clin Immunol Immunopathol (1986) 0.78
HTLV-III infection after bone marrow transplantation. Blood (1986) 0.78
HIV infection: facts and hypotheses. Immunol Today (1986) 0.77
Prognosis in HIV-1 infection predicted by the quantity of virus in plasma. Science (1996) 18.38
The Multicenter AIDS Cohort Study: rationale, organization, and selected characteristics of the participants. Am J Epidemiol (1987) 17.36
Plasma viral load and CD4+ lymphocytes as prognostic markers of HIV-1 infection. Ann Intern Med (1997) 16.44
Consistent viral evolutionary changes associated with the progression of human immunodeficiency virus type 1 infection. J Virol (1999) 10.41
Cell migration and chimerism after whole-organ transplantation: the basis of graft acceptance. Hepatology (1993) 8.76
Kidney transplantation under FK 506. JAMA (1990) 7.45
Quantitation of HIV-1 RNA in plasma predicts outcome after seroconversion. Ann Intern Med (1995) 6.90
The many faces of multivisceral transplantation. Surg Gynecol Obstet (1991) 6.89
Effectiveness of precautions against droplets and contact in prevention of nosocomial transmission of severe acute respiratory syndrome (SARS). Lancet (2003) 6.23
KSHV antibodies among Americans, Italians and Ugandans with and without Kaposi's sarcoma. Nat Med (1996) 5.96
Evidence for gene transfer and expression of factor IX in haemophilia B patients treated with an AAV vector. Nat Genet (2000) 5.80
Abdominal organ cluster transplantation for the treatment of upper abdominal malignancies. Ann Surg (1989) 5.78
Infections after liver transplantation. An analysis of 101 consecutive cases. Medicine (Baltimore) (1988) 5.77
Reversibility of lymphomas and lymphoproliferative lesions developing under cyclosporin-steroid therapy. Lancet (1984) 5.74
Immunosuppression of canine, monkey, and baboon allografts by FK 506: with special reference to synergism with other drugs and to tolerance induction. Surgery (1988) 5.03
Liver, kidney, and thoracic organ transplantation under FK 506. Ann Surg (1990) 5.01
An improved technique for multiple organ harvesting. Surg Gynecol Obstet (1987) 4.73
IMMUNOSUPPRESSION WITH FR 900506 FOR CANINE KIDNEY AND LIVER TRANSPLANTATION. Surg Res Commun (1987) 4.68
Liver transplantation (1). N Engl J Med (1989) 4.53
Risk factors for seroconversion to human immunodeficiency virus among male homosexuals. Results from the Multicenter AIDS Cohort Study. Lancet (1987) 4.33
Heterotopic heart transplantation in the rat receiving FK-506 alone or with cyclosporine. Transplant Proc (1987) 4.21
Seroconversion to antibodies against Kaposi's sarcoma-associated herpesvirus-related latent nuclear antigens before the development of Kaposi's sarcoma. N Engl J Med (1996) 4.13
Baboon-to-human liver transplantation. Lancet (1993) 4.01
Replacement of donor lymphoid tissue in small-bowel transplants. Lancet (1991) 3.85
A global emerging disease of Klebsiella pneumoniae liver abscess: is serotype K1 an important factor for complicated endophthalmitis? Gut (2002) 3.73
Natural history of human immunodeficiency virus type 1 viremia after seroconversion and proximal to AIDS in a large cohort of homosexual men. Multicenter AIDS Cohort Study. J Infect Dis (2000) 3.73
Immunosuppressive effect of FK-506 on in vitro lymphocyte alloactivation: synergism with cyclosporine A. Transplant Proc (1987) 3.73
Regulation of cellular interferon production: enhancement by antimetabolites. Proc Natl Acad Sci U S A (1970) 3.66
Early infections in kidney, heart, and liver transplant recipients on cyclosporine. Transplantation (1983) 3.60
Transplantation of multiple abdominal viscera. JAMA (1989) 3.59
Prospective multicenter study of thyroiscarcinoma treatment: initial analysis of staging and outcome. National Thyroid Cancer Treatment Cooperative Study Registry Group. Cancer (1998) 3.55
IN VITRO IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 ON HUMAN T LYMPHOCYTE ALLOACTIVATION. Surg Res Commun (1987) 3.46
Selected topics on FK 506, with special references to rescue of extrahepatic whole organ grafts, transplantation of "forbidden organs," side effects, mechanisms, and practical pharmacokinetics. Transplant Proc (1991) 3.40
Stress-induced relapse to heroin and cocaine seeking in rats: a review. Brain Res Brain Res Rev (2000) 3.40
The relation of preoperative coagulation findings to diagnosis, blood usage, and survival in adult liver transplantation. Transplantation (1985) 3.38
Orthotopic liver transplantation for patients with hepatitis B virus-related liver disease. Hepatology (1991) 3.34
The effects on survival of early treatment of human immunodeficiency virus infection. N Engl J Med (1992) 3.32
Kidney transplantation under FK 506 immunosuppression. Transplant Proc (1991) 3.31
Human vascular endothelial cell adhesion receptors for Plasmodium falciparum-infected erythrocytes: roles for endothelial leukocyte adhesion molecule 1 and vascular cell adhesion molecule 1. J Exp Med (1992) 3.30
Development of an in vitro organ culture model to study transmission of HIV-1 in the female genital tract. Nat Med (2000) 3.30
Cell-mediated immune response to human immunodeficiency virus (HIV) type 1 in seronegative homosexual men with recent sexual exposure to HIV-1. J Infect Dis (1992) 3.27
Use of OKT3 with cyclosporin and steroids for reversal of acute kidney and liver allograft rejection. Nephron (1987) 3.26
The pathology of posttransplant lymphoproliferative disorders occurring in the setting of cyclosporine A-prednisone immunosuppression. Am J Pathol (1988) 3.24
Liver transplantation before 1 year of age. J Pediatr (1987) 3.15
In Vitro Immunosuppressive Effects of FK506 in Combination With Other Drugs. Transplant Proc (1988) 3.15
The transplanted kidney as a source of cytomegalovirus infection. N Engl J Med (1975) 3.09
Fungal infections in liver transplant recipients. Transplantation (1985) 3.07
A multifactorial system for equitable selection of cadaver kidney recipients. JAMA (1987) 3.01
Tobacco and tuberculosis: a qualitative systematic review and meta-analysis. Int J Tuberc Lung Dis (2007) 3.00
Biliary tract complications in human orthotopic liver transplantation. Transplantation (1987) 2.95
Outcome analysis of 71 clinical intestinal transplantations. Ann Surg (1995) 2.95
Liver transplantation (2). N Engl J Med (1989) 2.93
Molecular basis of sequestration in severe and uncomplicated Plasmodium falciparum malaria: differential adhesion of infected erythrocytes to CD36 and ICAM-1. J Infect Dis (1991) 2.87
Experience in 1,000 liver transplants under cyclosporine-steroid therapy: a survival report. Transplant Proc (1988) 2.87
Equitable allocation of extrarenal organs: with special reference to the liver. Transplant Proc (1988) 2.85
The use of FK-506 for small intestine allotransplantation. Inhibition of acute rejection and prevention of fatal graft-versus-host disease. Transplantation (1990) 2.79
Infections with cytomegalovirus and other herpesviruses in 121 liver transplant recipients: transmission by donated organ and the effect of OKT3 antibodies. J Infect Dis (1988) 2.76
THE IMMUNOSUPPRESSIVE EFFECTS OF FR 900506 IN RATS RECEIVING HETEROTOPIC CARDIAC ALLOGRAFTS. Surg Res Commun (1987) 2.75
The association of Epstein-Barr virus with smooth-muscle tumors occurring after organ transplantation. N Engl J Med (1995) 2.68
Incidence and treatment of rejection episodes in primary orthotopic liver transplantation under FK 506. Transplant Proc (1991) 2.59
Dopamine infusion: a simpler formula. Indian Pediatr (1994) 2.51
A randomized controlled trial of a reduced daily dose of zidovudine in patients with the acquired immunodeficiency syndrome. The AIDS Clinical Trials Group. N Engl J Med (1990) 2.50
FK506 "rescue" for resistant rejection of renal allografts under primary cyclosporine immunosuppression. Transplantation (1994) 2.50
Kaposi's sarcoma-associated herpesvirus infection prior to onset of Kaposi's sarcoma. AIDS (1996) 2.49
A randomized trial of primary liver transplantation under immunosuppression with FK 506 vs cyclosporine. Transplant Proc (1991) 2.49
The prognostic and pathophysiologic role of pro- and antiinflammatory cytokines in severe malaria. J Infect Dis (1999) 2.49
Opportunistic lung infection due to "Pittsburgh Pneumonia Agent". N Engl J Med (1979) 2.49
New bacterial agent of pneumonia isolated from renal-transplant recipients. Lancet (1979) 2.45
Human immunodeficiency virus type 1 (HIV-1) infection a median of 18 months before a diagnostic western blot. Evidence from a cohort of homosexual men. Ann Intern Med (1989) 2.44
Mechanisms of immunosuppression in cytomegaloviral mononucleosis. J Infect Dis (1980) 2.41
Increasing resistance of Streptococcus pneumoniae to fluoroquinolones: results of a Hong Kong multicentre study in 2000. J Antimicrob Chemother (2001) 2.41
Liver transplantation across ABO blood groups. Surgery (1986) 2.39
Prioritization and organ distribution for liver transplantation. JAMA (1994) 2.38
Toxicology of FK-506 in the Lewis rat. Transplant Proc (1987) 2.37
The pathophysiology of malaria. Adv Parasitol (1992) 2.33
The antibody crossmatch in liver transplantation. Surgery (1986) 2.33
The incidence, timing, and management of biliary tract complications after orthotopic liver transplantation. Ann Surg (1994) 2.32
Liver transplantation for type IV glycogen storage disease. N Engl J Med (1991) 2.31
Interaction of cytomegalovirus with leukocytes from patients with mononucleosis due to cytomegalovirus. J Infect Dis (1977) 2.30
FK 506 in clinical kidney transplantation. Transplant Proc (1991) 2.29
Limbal stem cell deficiency: concept, aetiology, clinical presentation, diagnosis and management. Indian J Ophthalmol (2000) 2.28
The hepatotropic influence of cyclosporine. Surgery (1990) 2.27
Genes involved in senescence and immortalization. Curr Opin Cell Biol (2000) 2.27
Variables influencing condom use in a cohort of gay and bisexual men. Am J Public Health (1988) 2.26
Conversion of liver allograft recipients from cyclosporine to FK 506-based immunosuppression: benefits and pitfalls. Transplant Proc (1991) 2.26
Combination therapy with zidovudine and didanosine selects for drug-resistant human immunodeficiency virus type 1 strains with unique patterns of pol gene mutations. J Infect Dis (1994) 2.26